Tag: clinical trial communication

Recruitment Challenges in Pediatric Rare Disease Trials

August 8, 2025

Recruitment Challenges in Pediatric Rare Disease Trials Addressing Recruitment Challenges in Pediatric Rare Disease Trials Why Pediatric Rare Disease Trials Are Exceptionally Challenging Rare diseases disproportionately affect children—around 50–75% of all rare diseases begin in childhood. Yet recruiting pediatric patients for clinical trials presents unique and often compounding challenges. These include medical, ethical, logistical, and…

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Ensuring Comprehension During Re-Consent in Clinical Trials

June 26, 2025

digi

Ensuring Comprehension During Re-Consent in Clinical Trials Ensuring Participant Comprehension During Re-Consent in Clinical Trials Re-consenting trial participants is not merely a procedural step — it is an ethical obligation that ensures patients continue participation with full awareness of any new risks, changes, or information. However, simply obtaining a signature does not equate to understanding….

Informed Consent and Ethics Committees, Re-Consent Procedures

Patient-Centric Communication Techniques to Improve Retention in Clinical Trials

June 14, 2025

digi

Patient-Centric Communication Techniques to Improve Retention in Clinical Trials Patient-Centric Communication Techniques to Improve Retention in Clinical Trials Effective communication is at the heart of successful clinical trial retention. While recruitment draws participants into a study, communication keeps them engaged and compliant throughout. A patient-centric approach goes beyond protocol instructions—it fosters understanding, trust, and satisfaction….

Patient Recruitment and Retention, Retention Strategies

Language Barriers and Translation in Informed Consent for Clinical Trials

June 12, 2025

digi

Language Barriers and Translation in Informed Consent for Clinical Trials Overcoming Language Barriers in Informed Consent: Translation Strategies for Clinical Trials In multinational and multilingual clinical trials, language barriers pose a significant challenge to obtaining truly informed consent. Participants must understand the study, risks, and their rights — regardless of their language. This article provides…

Informed Consent and Ethics Committees, Informed Consent Process